(Q45418301)

14 December 2017

title

Oncolytic viruses derived from the gamma34.5-deleted herpes simplex virus recombinant R3616 encode a truncated UL3 protein (English)

1 reference

14 December 2017

1 reference

Megan J Dambach

1

1 reference

14 December 2017

Jordan Trecki

series ordinal

2

1 reference

14 December 2017

Natalia Martin

series ordinal

3

1 reference

14 December 2017

Nancy S Markovitz

series ordinal

4

1 reference

14 December 2017

language of work or name

1 reference

30 March 2006

1 reference

14 December 2017

1 reference

14 December 2017

volume

13

1 reference

14 December 2017

issue

5

1 reference

14 December 2017

page(s)

891-898

1 reference

Herpes vector-mediated gene transfer in treatment of diseases of the nervous system

14 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.02.006

Oncolytic viruses: clinical applications as vectors for the treatment of malignant gliomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.02.006

Mapping of herpes simplex virus-1 neurovirulence to gamma 134.5, a gene nonessential for growth in culture

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.02.006

Herpes simplex virus type 1 deletion variants 1714 and 1716 pinpoint neurovirulence-related sequences in Glasgow strain 17+ between immediate early gene 1 and the 'a' sequence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.02.006

A herpes simplex virus type 1 gamma34.5 second-site suppressor mutant that exhibits enhanced growth in cultured glioblastoma cells is severely attenuated in animals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.02.006

Peripheral replication and latency reactivation kinetics of the non-neurovirulent herpes simplex virus type 1 variant 1716

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.02.006

Replication, establishment of latency, and induced reactivation of herpes simplex virus gamma 1 34.5 deletion mutants in rodent models

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.02.006

The herpes simplex virus type 1 strain 17 open reading frame RL1 encodes a polypeptide of apparent M(r) 37K equivalent to ICP34.5 of herpes simplex virus type 1 strain F.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.02.006

Histopathological responses in the CNS following inoculation with a non-neurovirulent mutant (1716) of herpes simplex virus type 1 (HSV 1): relevance for gene and cancer therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.02.006

Preclinical safety evaluation of G207, a replication-competent herpes simplex virus type 1, inoculated intraprostatically in mice and nonhuman primates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.02.006

Cell type and cell state determine differential in vitro growth of non-neurovirulent ICP34.5-negative herpes simplex virus types 1 and 2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.02.006

Selective in vitro replication of herpes simplex virus type 1 (HSV-1) ICP34.5 null mutants in primary human CNS tumours--evaluation of a potentially effective clinical therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.02.006

Attenuated multi–mutated herpes simplex virus–1 for the treatment of malignant gliomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.02.006

HSV1716 injection into the brain adjacent to tumour following surgical resection of high-grade glioma: safety data and long-term survival

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.02.006

Oncolytic herpes simplex virus vectors for cancer virotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.02.006

ICP34.5 deleted herpes simplex virus with enhanced oncolytic, immune stimulating, and anti-tumour properties

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.02.006

Conditionally replicating herpes simplex virus mutant, G207 for the treatment of malignant glioma: results of a phase I trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.02.006

The potential for efficacy of the modified (ICP 34.5(-)) herpes simplex virus HSV1716 following intratumoural injection into human malignant glioma: a proof of principle study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.02.006

Toxicity evaluation of replication-competent herpes simplex virus (ICP 34.5 null mutant 1716) in patients with recurrent malignant glioma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.02.006

Intracarotid delivery of oncolytic HSV vector G47Delta to metastatic breast cancer in the brain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.02.006

A novel multiply-mutated HSV-1 strain for the treatment of human brain tumors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.02.006

Therapeutic efficiency and safety of a second-generation replication-conditional HSV1 vector for brain tumor gene therapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.02.006

The complete DNA sequence of the long unique region in the genome of herpes simplex virus type 1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.02.006

Small dense nuclear bodies are the site of localization of herpes simplex virus 1 U(L)3 and U(L)4 proteins and of ICP22 only when the latter protein is present

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.02.006

The herpes simplex virus type 2 UL3 open reading frame encodes a nuclear localizing phosphoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.02.006

Effect of gene location on the evolutionary rate of amino acid substitutions in herpes simplex virus proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.02.006

Repair and genetic consequences of endogenous DNA base damage in mammalian cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.02.006

Ribonucleotide reductase: a determinant of 5-bromodeoxyuridine mutagenesis in phage T4.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.02.006

Quality control by DNA repair

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.02.006

On the mutation rate of herpes simplex virus type 1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.02.006

Characterization of herpes simplex virus strains differing in their effects on social behaviour of infected cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.02.006

A generalized technique for deletion of specific genes in large genomes: alpha gene 22 of herpes simplex virus 1 is not essential for growth.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.02.006

Rescue of a herpes simplex virus type 1 neurovirulence function with a cloned DNA fragment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.02.006

inferred from DOI database lookup

7 January 2021

based on heuristic

The open reading frames UL3, UL4, UL10, and UL16 are dispensable for the replication of herpes simplex virus 1 in cell culture

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2006.02.006

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.YMTHE.2006.02.006

1 reference

release_h7xxq7uitbhw3ha7bdhu3u6why

14 December 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/h7xxq7uitbhw3ha7bdhu3u6why

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference